These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Genotype and function analyses of four inherited dysfibrinogenemia pedigree caused by Arg16 amino acid substitution in fibrinogen Aα chain]. Jiang LL; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Xi XD; Wang HL Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):475-9. PubMed ID: 22967385 [TBL] [Abstract][Full Text] [Related]
26. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo. Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317 [TBL] [Abstract][Full Text] [Related]
27. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation. Casini A; Brungs T; Lavenu-Bombled C; Vilar R; Neerman-Arbez M; de Moerloose P J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264 [TBL] [Abstract][Full Text] [Related]
28. Rare deletion from the fibrinogen Bβ gene in a patient with a provoked venous thrombotic event. Shen YM; Sarode R; Bhogaraju A; Brennan S Blood Coagul Fibrinolysis; 2011 Oct; 22(7):613-5. PubMed ID: 21959590 [TBL] [Abstract][Full Text] [Related]
29. [Functional study of abnormal fibrinogen caused by Arg275His mutation in fibrinogen γ chain]. Zhou JY; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Xi XD; Wang HL Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):190-4. PubMed ID: 23683413 [TBL] [Abstract][Full Text] [Related]
30. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release. Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754 [TBL] [Abstract][Full Text] [Related]
31. Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders? Bevan DH Thromb Res; 2009 Dec; 124 Suppl 2():S12-6. PubMed ID: 20109651 [TBL] [Abstract][Full Text] [Related]
32. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function. Undas A; Zdziarska J; Iwaniec T; Stepien E; Skotnicki AB; de Moerloose P; Neerman-Arbez M Thromb Haemost; 2009 May; 101(5):975-6. PubMed ID: 19404553 [No Abstract] [Full Text] [Related]
33. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen. Kotlín R; Reicheltová Z; Malý M; Suttnar J; Sobotková A; Salaj P; Hirmerová J; Riedel T; Dyr JE Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467 [TBL] [Abstract][Full Text] [Related]
34. Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A. Casini A; De Maistre E; Casini-Stuppi V; Fontana P; Neerman-Arbez M; de Moerloose P Blood Coagul Fibrinolysis; 2014 Apr; 25(3):280-2. PubMed ID: 24389539 [TBL] [Abstract][Full Text] [Related]
36. Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain. Rosenberg JB; Newman PJ; Mosesson MW; Guillin MC; Amrani DL Thromb Haemost; 1993 Mar; 69(3):217-20. PubMed ID: 8470043 [TBL] [Abstract][Full Text] [Related]
37. Novel fibrinogen mutation (gamma 313 Ser-->Asn) associated with hypofibrinogenemia in two unrelated families. Meyer M; Bergmann F; Brennan SO Blood Coagul Fibrinolysis; 2006 Jan; 17(1):63-7. PubMed ID: 16607083 [TBL] [Abstract][Full Text] [Related]
38. Characterisation of a novel nonsense mutation in FGG (Fibrinogen Poznan) causing hypofibrinogenaemia with a mild bleeding tendency. Zawilska K; Undas A; Fish RJ; Molendowicz-Portala L; De Moerloose P; Neerman-Arbez M Thromb Haemost; 2010 Mar; 103(3):677-9. PubMed ID: 20135062 [No Abstract] [Full Text] [Related]
39. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy. Miesbach W; Galanakis D; Scharrer I Blood Coagul Fibrinolysis; 2009 Jul; 20(5):366-70. PubMed ID: 19357502 [TBL] [Abstract][Full Text] [Related]
40. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia. Asselta R; Spena S; Duga S; Peyvandi F; Malcovati M; Mannucci PM; Tenchini ML Haematologica; 2002 Aug; 87(8):855-9. PubMed ID: 12161363 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]